2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC871
Submitter : Ms. Pat LeMond Date & Time: 10/17/2005 10:10:01
Organization : Ms. Pat LeMond
Category : Individual Consumer
Issue Areas/Comments
See Attachment:

As you review the data on Plan B, we urge you to consider that a woman's access to EC plays a critical role in preventing unintended pregnancy and reducing the need for abortion. We support the approval of Barr Laboratories' application. Thank you for your consideration of this request.


Pat LeMond